Rebound insomnia and newer hypnotics

@article{Lader2005ReboundIA,
  title={Rebound insomnia and newer hypnotics},
  author={Malcolm Harold Lader},
  journal={Psychopharmacology},
  year={2005},
  volume={108},
  pages={248-255}
}
  • M. Lader
  • Published 2005
  • Psychology, Medicine
  • Psychopharmacology
The prescription of hypnotics, mostly benzodiazepines, continues at a high level. One problem with their use is rebound insomnia: upon discontinuation sleep worsens compared with pretreatment levels. Factors influencing rebound include the type of subject, the duration of action of the hypnotic, the dosage and perhaps duration of treatment. The detection of rebound requires both sleep-laboratory and clinical studies with night-by-night analyses of individual patient data. This review… 
Rebound and withdrawal with benzodiazepine and non-benzodiazepine hypnotic medication
TLDR
The purpose of this chapter is to review briefly the clinical problems that can be encountered when discontinuing hypnotic drugs within the normal therapeutic context.
Clinical Management of Patients with Insomnia
TLDR
Zopiclone has been proven as a drug that favourably balances sleep induction and maintenance as well as an improvement in daytime well-being with a low potential for adverse effects in the symptomatic treatment of insomnia.
Pharmacotherapy of insomnia: Practice and prospects
TLDR
An overview is presented of the currently available hypnotics, of which benzodiazepines are still the most widely prescribed, and new drugs which bind to specific receptor subtypes or which are partial Benzodiazepine receptor agonists might overcome the disadvantages associated with chronic benzodiazine use.
Zopiclone: Is there any dependence and abuse potential?
  • M. Lader
  • Psychology, Medicine
    Journal of Neurology
  • 2009
TLDR
Zopiclone has substantial advantages over the benzodiazepines in terms of dependence and abuse potential and cross-tolerance to zopiclones may help in a regimen to withdraw from the latter drugs.
Management of insomnia: current trends
TLDR
Research examining other mechanisms of action suggest that agents which modulate the histaminergic, serotonergic, melontonergic, and hypocretin/ orexin and perhaps gamma-aminobutyric acid B systems could play a promising role in management of insomnia.
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
TLDR
The systematic review provided in this report suggests that an agnostic approach to cost-effectiveness is required for the use of hypnotic drugs for insomnia and it is suggested that further consideration should be given to a formal trial to allow head-to-head comparison of some of the key drugs in a double-blind RCT lasting at least 2 weeks, and of sufficient size to draw reasonable conclusions.
An integrative approach to the management of insomnia
TLDR
Because of its multifaceted and variable aetiopathogenesis, chronic insomnia necessitates a multidimensional treatment plan and two or more treatment modalities are combined and their application is based on a sound patient-doctor relationship.
...
1
2
3
4
...

References

SHOWING 1-10 OF 108 REFERENCES
Rebound insomnia: its determinants and significance.
Insomnia and its treatment. When are hypnotics justified?
Symptomatic treatment of transient insomnias is advisable, for without treatment these sleep disorders may become persistent. The drugs of choice are the benzodiazepine hypnotics, which have minimal
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
TLDR
Rebound insomnia occurred following withdrawal of triazolam, nitrazepam, and flunitsepam after they had been given in only single, nightly doses for short periods, attributed to the short and intermediate half-lives of these drugs.
Rebound insomnia: a new clinical syndrome.
Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods. The intense worsening of
Benzodiazepine withdrawal and rebound insomnia
TLDR
This article does not remove many important doubts concerning the wisdom of abrupt withdrawal following the long-term use of benzodiazepine hypnotics, and suggests that rebound insomnia is not confined to, and cannot be properly assessed by recording, a single night of sleep.
Rebound insomnia and rebound anxiety: a review.
TLDR
Evidence suggests that drugs producing rebound insomnia and rebound anxiety show a more rapid development of tolerance and greater potential for drug dependence than benzodiazepines where the parent compound or its metabolites have a long elimination half-life.
Quazepam: Hypnotic Efficacy and Side Effects
  • A. Kales
  • Medicine, Psychology
    Pharmacotherapy
  • 1990
TLDR
Quazepam is a benzodiazepine hypnotic that can be useful in the adjunctive pharmacologic treatment of insomnia and is more effective with short‐term use, and with continued use it maintains its efficacy in contrast to both of these drugs which show rapid development of tolerance.
Effects of zopiclone on the sleep of chronic insomniacs.
The purpose of this study was to evaluate the short- and intermediate-term (21 days) effectiveness, as well as the carryover and withdrawal effects of 7.5 mg of zopiclone, a new short-acting hypnotic
Midazolam: dose-response studies of effectiveness and rebound insomnia.
TLDR
There was less effectiveness on the last 3 drug nights, indicating a potential for the development of tolerance over a relatively short period of time and following withdrawal there was a marked dose-related worsening of sleep above baseline levels (rebound insomnia).
Lorazepam: effects on sleep and withdrawal phenomena.
TLDR
There was a marked and significant worsening of sleep above baseline levels (rebound insomnia) on the third night as well as significant increases in tension and anxiety the next day following drug withdrawal.
...
1
2
3
4
5
...